CLINICAL_TRIALS
trial_result
· 2021-09-20
Clinical Trial Update: Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients [Phase 3]
Summary
Phase 3 trial comparing Pyronaridine Artesunate (3:1) to Coartem in Plasmodium falciparum malaria; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 3 | Status: COMPLETED | Results posted: 2021-09-20